ParenteBeard Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$18K Sell
591
-25,923
-98% -$743K 0.21% 41
2014
Q3
$744K Buy
26,514
+7,534
+40% +$211K 0.31% 46
2014
Q2
$534K Buy
18,980
+5
+0% +$143 0.23% 54
2014
Q1
$578K Hold
18,975
0.29% 48
2013
Q4
$551K Sell
18,975
-1,950
-9% -$56.8K 0.22% 72
2013
Q3
$570K Buy
20,925
+553
+3% +$15K 0.28% 49
2013
Q2
$541K Buy
+20,372
New +$563K 0.25% 56

Other funds holding PFE

ParenteBeard Wealth Management's PFE Position: Q4 2014 in Review

ParenteBeard Wealth Management reduced its Pfizer (PFE) stake by 98% in Q4 2014, selling an estimated $743K and leaving 591 shares worth $18K. The position accounts for 0.21% of the portfolio, ranked #41.

ParenteBeard Wealth Management first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. The position peaked at $744K in Q3 2014. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • ParenteBeard Wealth Management held 591 shares of Pfizer worth $18K as of Q4 2014.
  • ParenteBeard Wealth Management sold 25,923 Pfizer shares in Q4 2014, an estimated $743K.
  • Pfizer made up 0.21% of ParenteBeard Wealth Management's portfolio in Q4 2014, its #41 holding.
  • ParenteBeard Wealth Management first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
  • ParenteBeard Wealth Management's Pfizer position peaked at $744K in Q3 2014.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on ParenteBeard Wealth Management's 13F filing for Q4 2014, filed 28 Jan 2015.